GH s e c r e t i o n was e v a l u a t e d i n 54 s h o r t p a t i e n t s w i t h mean g r o w t h r e t a r d a t i o n o f 3 . 3
SD ( 32 M and 22 F aged 5 t o 19
y e a r s ) , comparing t h e i r peak response t o GRF 1-44 S a n o f i 2 p g l k g I V (GRF P) and t o 2 c o n v e n t i o n a l pharrnacologic s t i m u l i ( a r g i n i n e , i n s u l i n , glucagon, o r n i t h i n e ) (PS P) w i t h t h e peak v a l u e o f t h e i r s l e e p s e c r e t i o n (SS P ) . GRF P was more s i g n i f i c a n t l y c o r r e l a t e d w i t h PS P ( r = 0.53, p < 0.001) t h a n w i t h SS P ( r = 0.33, p<0.02).
The p a t i e n t s have been c l a s s i f i e d i n t o 5 groups a c c o r d i n g as u s u a l l y t o t h e s l e e p and pharmacologic GH l e v e l s : group I = 2fi e n d o c r i n o l o q i c a l l y n o r m a l w i t h b o t h PS and SS peaks) 10 ng/ml; g r o u p X I = 5 c o m p l e t e l y GH d e f i c i e n t w i t h b o t h PS and SS peaks < 6 n g / m l ; group I11 = 8 p a r t i a l l y d e f i c i e n t w i t h b o t h PS and SS P 6 t o 10 ng/ml; group I V = 9 w i t h n o r m a l SS P and l o w PS P; g r o u p V = 6 w i t h l o w SS P and n o r m a l PS P.
GRF P (R ' SEM) was 39 ' 5.6 n g / m l i n group I, 12 ' 3.4 i n g r o u p 11, 24 ' 3.7 i n group 111, 12 ' 5.0 i n group I V and 23 '5.3 n g l m l i n group V. I t was s i g n i f i c a n t l y h i g h e r i n group I t h a n I n a l l o t h e r s ( I vs I 1 and vs I V p < 0.001, I vs I11 and vs V p < 0 . 0 5 ) . However t h e r e was a l a r g e o v e r l a p o f t h e GRF P between t h e 5 groups. It i s concluded t h a t t h e GRF t e s t c o n t r i b u t e s t o t h e e v a l u a t i o n o f GH s e c r e t i o n b u t p r o b a b l y does n o t improve t h e d e f i n i t i o n o f a t y p i c a l d e f i c i e n c i e s .
L. Gelander*, K. A l b e r t s s o n -W l k l a n d 68 Department o f P e d i a t r i c s I 1 and P h y s i o l o g y U n i v e r s i t y o f GGteborg, GGteborg, Sweden GROWTH HORMONE (Gtl) RCLCASE AFTER GROWTll IIOHMONE RE-LEASING HORMONE(GRt1) CORRELATES TO CNDOGCNOUS 24-tl-Gll SECRETION I N 38 SHORT CHILDREN I n 38 s h o r t c h i l d r e n we f o l l o w e d t h e endogenous GH-secretion f11r 2 4 h ( s a m p l i n g i n t e r v a l s o f 20 m l n ) . T h i s was immediately f o l l o w e d by an i v i n j . o f l u g / k g o f GRH 1-27. GI1 was c s t l r n a t c d c v c r y 151nln t h e f o l l o w i n g two hours. The aim was t o s t u d y i f t h e spontaneous GH-secretion, measured d u r i n g t h e 24-h-period, had any r e l a t i o n t o o r i n f l u e n c e d on t h e GH-release induced by GRII. P a t i e n t s : The chron. age o r t h e c h i l d r e n ranged 3-13y. 32 were p r cp u b e r t a l and 7 showed s i g n s o f e a r l y p u b e r t y . 6 c h i l d r e n had a Gliresponse t o i n s u l i n -a r g i n i n e t e s t below 14mU/1 ( c l a s s i c a l l y GtI-deD.
A l l c h i l d r e n were o t h e r w i s e considered h e a l t h y . R e s u l t s : I n 32 c h i l d r e n t h e 24-h-GH-secretion v a r l e d bctween 54-1500 niU AUC(Area Under t h e Curve) over b a s a l and w i t h a mean o f 4.1-26mU/1.
The Gti-def. c h~l d r e n showed a dlmlnshed 24-h-GH-secrc.-t l o n . An i n c r e a s e d GH-secretion a f t e r GRH was found i n a l l buL orle o f t h e 30 c h i l d r e n . Max.leve1 o f 107 " l 4 m~/ 1 , range 17-296mU/1. [\ h i g h endogenous 24-h-GH s e c r e t i o n a f t e r GRll when estimated e i t l l c r as AUC over basal(r=0.47;p<0.01) o r as mean o f t h e 24-h-period(r:: 0.40;p<0.01).
The endogenous GH-secretion measured d u r l n g 3h b e r i~r e CRH i n j . d i d n o t i n f l u e n c e on t h e GH-response t o GRH. However, v e r y few o f t h e c h i l d r e n had endogenous s e c r e t i o n d u r i n g these r n o r n l n~j l i . 
Conclusions: The c o r r e l a t i o n between a h l g h endogenous 24-h-GtI-sec r c t i o n and a h i g h GH-response t o GRH, indicates t h a t t h c GRII LesL may he a u s e f u l t o o l t o e s t i m a t e t h e a b i l i t y t o r e l e a s e GH

66
O.Bechinger* and ~.~.~e l l e r 69 H.Sangiovanni*, S.Donati*, A.Ruffini*. E . C a c~i a~i .
Oep. P e d i a t r i c s and Oep. Neurology, U n i v e r s i t y o f Ulm, Ulm, West Germany 2nd Pediatric Clinic, University of Bologna, I t a l y
GH SECRETION DURING SLEEP AN0 GRF-STIMULATION I N GH-DEFICIENT AN0 SHORT NORMAL CHILDREN DI SCORDANCES I N R E L E A S I N G T E S T S I N O E T E C T l N G THE S I T E OF THE DEFI-C l E N C Y I N P I T U I T A R Y PATIENTS.
I n 22 short-statured children G H was determined every 20 minutes f r m 20:OO to 8:00 with continous EEG registration to demonstrate stage 4 sleep. Peak and mean G H values were analyzed. A t 8:00 a bolus of 1 pg/kg GRF 1-44 was given and G H measured every 15 minutes. Group A (n.12) had been previously diagnosed as GHdeficient (GHO)(peak G H < 6 ng/ml i n 2 independent tests, height and growth rate < -2 SOS). These children had been treated with G H for 1.5-12 years and were off treatment for > 6 months when reexamined. Group B (n=2) had been diagnosed and treated as G H D but showed normal growth velocity after cessation of therapy. Both had reached Tanner 111 and might be classified as transient GHD. Group C consisted of 8 children i n whom G H rose above 8 ng/ml i n at least one conventional test. Table 1 gives meant EM for chronological age (CA), bone age @A), height (SOS) and growth velocity (cmlyear), peak (P) and mean (M) G H values during sleep and peak G H after GRF (nglml). Individual vdlues i n group 8.
The GHRF test i s thought to be able to differentiate pitutary from hypothalamic defects in GH-deficient patients. Our purpose uas to verify i f the informathn obtained via GHRF test uas in agreement uith that of b y the TRH and LHRH tests performed in pituitary subjects followed from 2 to 12 yrs. Subjects: 36 pituitary patients subdivided into 3 groups: I ) 11 uith normal puberty; 11) 9 uith pharmacologically induced puberty; 111) 16 prepubertal with bane age ( 12 yrs. G R F test (3 ug/Kg i v ) : a peak 24 ng/ml uas present in 10 subjects in group 1 (91% hypothalamic defect). 3 in group I 1 (33% hypothalamic), 9 in group I11 (56% hypothalamic). TRH test (100 ug i v ) : group I normal response, no subject neeccd replacement therapy; group 11 only one with a normal h y p o t h a l a m o -p i t u i t a r y -t t~y -roidal axis. and 8 with hypothyroidism and a delayed and prolonged TSH resporlse l o test the hypothesis of an hypothalaaic origin of the growth retardation observed i n thalassemic children at the time of puberty, 18 males and 6 females. aged 9 to 20 years, have been studied under high-regimen blood transfusion and desferrioxamine therapy for the GH response to G R F (2uglkg. 1-44 NH2, Sanofi). conventional tests and sleep. Pubertal stages according to Tanner rere as follows: 6 M and 4 F at stage 1. 8 M at stage 2 and 4 M and 2 F at stage 3 or aore. 13 1 and 5 F shoued evidences of hypogonadotropic hypogonadism. The conventional test responses uere normal i n 17 and lau i n 7 patients. A blunted response to G R F was seen i n 2 patients uhich previously shou normal pharmacological response. The GH nocturnal peak uas above 20 uI/ml in 14 patients. 8 have a decreased nocturnal secretion i n contrast to normal G R F response. The nean values of the nocturnaland GRF-induced peaks uere belou normal for the age. There was no correlation between the conventional GH response and G R F or sleep response. The nocturnal response was correlated uith the GRF-induced peak but not uith either bone-age retardation. grouth velocity or f e r r i t i n blood level. I n conclusion thalassemic children shou evidences of GH dysfunction suggesting a priaary hypothalamic dysfunction andlor an secondary effect of hypogonadism on the GH secretion l i k e l y related to hemosiderosis. A f t e r c r a n i a l i r r a d i a t i o n f o r acute lymphoblastic lwkrmia(ALL) low GH response t o pharmacological s t i m l a t i o n and/or & r i n g sleep has been considered as evidence of neurosecretory dysfunction.In order t o f u r t h e r evaluate t h i s condition, the GH response t o hpCRF 1-44 (2 pg/kg IV) was studied i n 19 prepubertal c h i l d r e n i r r a d i a t e d a t a m a n CA of 4 10/12 + 8/12 y r (m + sem) w i t h 2400 r a d (12x200 r a d / l 6 days). They were eva--l u a t e d a f t e r a mean i n t e r v a l time o f 4 R/12 + 3/12 y r and compared t o an age m t c h c d group w i t h c o n s t i t u t i o n a l s h o r t s t a t u r e (CSS). 
C A 14.9'0.9 14.9/14.6 12.920.5 A f t e r i r r a d i a t i o n the i n d i v i d u a l Gti responses t o GRF, although n o t c o r r e l a t e d w i t h the GH-AITT peak o r SIC levels, were decreased i n 17/19 cases. Furthermore i n 4 cases w i t h n o m l q r m t h r o t e s and GII-AITT peaks (9-22 ng/ml) a decreased response t o GRF (12-19 nq/ml) was ohserved. These r e s u l t s suggest t h a t an impaired GH response t o GRF : 1 ) i s a frequent f i n d i n g a f t e r c r a n i a l i r r a d i a t i o n i n ALL ; 2) and may he the only s i g n o f GH nwrosecretory dysfunction. 
